Surge in Telemedicine One ‘Good’ Outcome from COVID-19 Crisis, Doctors Say
While there are few silver linings to the cloud created by COVID-19, the pandemic that has killed tens of thousands,…
Grace served as editor-in-chief for BioNews from June 2016 to June 2019 before returning to editing. A longtime newspaper editor and reporter, she was a Pulitzer Prize nominee for an investigative series into eye surgeries wrongly conducted outside a clinical trial. She holds a master’s degree in international relations from the University of Chicago and a bachelor's degree in political science from Rutgers University. Grace lives in France with her extended people-and-pets family.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
While there are few silver linings to the cloud created by COVID-19, the pandemic that has killed tens of thousands,…
Much work is ongoing in amyotrophic lateral sclerosis (ALS), as researchers look for better ways of treating people with…
Screening newborns for genetic diseases with treatments that can prevent crippling or deadly progression, especially for rare disorders, has a…
AveXis, which is running clinical trials of a promising gene therapy for spinal muscular atrophy (SMA) — and developing a potentially…